Wimberly Dayton
Family · Atlanta, GANPI 1104429281
Payments from drug & device makers
Across 175 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$739
- Viiv Healthcare Company$707
- Novo Nordisk$377
- Endo Pharmaceuticals Inc.$308
- Merck$253
- Johnson & Johnson$231
- plus $995 from 14 others
What the payments were for
- Food & beverage$3,609100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 30 | $739 |
| Viiv Healthcare Company | 35 | $707 |
| Novo Nordisk | 21 | $377 |
| Endo Pharmaceuticals Inc. | 14 | $308 |
| Merck | 12 | $253 |
| Johnson & Johnson | 12 | $231 |
| Napo Pharmaceuticals Inc | 9 | $162 |
| Lilly USA, LLC | 8 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $137 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| AbbVie | 5 | $98 |
| EMD Serono, Inc. | 4 | $79 |
| Lundbeck LLC | 3 | $69 |
| Pfizer | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Exact Sciences | 2 | $36 |
| GSK | 1 | $22 |
| Tolmar, Inc. | 1 | $21 |
| Halozyme Inc | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
How this compares
$3,609 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 25 | $461 |
| Atorvastatin Calcium | 26 | $283 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $254 |
| Losartan Potassium | 14 | $103 |
| Lisinopril | 20 | $103 |
| Tamsulosin Hcl | 13 | $101 |
| Meloxicam | 15 | $75 |
| Amlodipine Besylate | 12 | $68 |
| Sertraline Hcl | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other family in Atlanta
- Stacey TatroeAtlanta$38K
- Brandy HughesAtlanta$29K
- Cecile MartinAtlanta$23K
- Terri CowanAtlanta$21K
- Brandi Pinckney-GreeneAtlanta$18K
- Michelle SarievAtlanta$18K
- Christopher VreelandAtlanta$17K
- Angelica MillerAtlanta$15K
- Andrea Jefferson SaboorAtlanta$14K
- Allie McAllisterMarietta$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.